Incorporation of 4-14C-22,23-3 H-sitosterol Into diosgenin by Dioscorea deltoidea tissue suspension cultures

Sitosterol-4-¹⁴C-22,23-³H with a ³H/¹⁴C ratio of 5.0 was incorporated into diosgenin such that the ³H/¹⁴C ratio in diosgenin was approx. 2.3. The per cent of ¹⁴C incorporation was 0· and for ³H was 0·42%. The results indicate that C-23 is not involved in the transformation of sitosterol into diosgenin. The first step in the cyclization of the sterol side-chain may either involve oxygenation at C-26 or direct hydroxylation at C-22 via a mixed function oxidase system. Other indirect evidence suggests that the C-26 oxygenation mechanism is operative.     

Long non-coding RNA HNF1A-AS1 induces 5-FU resistance of gastric cancer through miR-30b-5p/EIF5A2 pathway

BackgroundGastric cancer (GC) is one of the leading causes of cancer-related deaths worldwide and chemoresistance is a major cause for its poor prognosis. Long non-coding RNAs (lncRNAs) are associated with cancer chemoresistance. The current study sought to explore the mechanism of lncRNA HNF1A antisense RNA 1 (HNF1A-AS1) in mediating 5-fluorouracil (5-FU) resistance of GC.MethodsqRT-PCR was performed to detect the expression level of HNF1A-AS1 in GC tissues and cells. Abnormal expression of HNF1A-AS1 in GC cells was induced by lentivirus infection. Protein levels of EIF5A2, E-Cadherin, Vimentin and N-Cadherin were detected using western blot. Competitive endogenous RNA (ceRNA) mechanisms were explored through luciferase assays and RNA immunoprecipitation (RIP) assays. Functional experiments of chemoresistance were performed by CCK-8 assays, colony formation assays and flow cytometry with the treatment of 5-FU. Mouse tumor xenograft assays were performed to verify the findings in vivo.ResultsThe findings showed HNF1A-AS1 was significantly upregulated in GC tissues especially in chemoresistance group. Findings from in vitro and in vivo experiments showed HNF1A-AS1 increased cell viability and proliferation, repressed apoptosis and promoted xenograft tumors growth in the presence of 5-FU. Mechanistic studies revealed HNF1A-AS1 promoted chemoresistance by facilitating epithelial mesenchymal transition (EMT) process through upregulating EIF5A2 expression and HNF1A-AS1 acted as a sponge of miR-30b-5p.ConclusionsThe findings from the current study showed HNF1A-AS1 promoted 5-FU resistance by acting as a ceRNA of miR-30b-5p and promoting EIF5A2-induced EMT process in GC. This indicates that HNF1A-AS1 is a potential therapeutic target for alleviating GC chemoresistance.     

Reverse phase high-pressure liquid chromatographic separation of retinoids,including retinylphosphate and mannosylretinylphosphate

Reverse phase hplc was used to separate retinylphosphate mannosylretinylphosphate from other retinoids. These phosphorylated retinoids constituted 12 and 42% of the extracted radioactivity in OEL mouse intestine at 3 and 24 h respectively after the intubation of [1-³H]retinol. A detailed procedure for the chemical synthesis of retinylphosphate is described.     

Antibody effector functions are associated with protection from respiratory syncytial virus

1. Download : Download high-res image (219KB)
2. Download : Download full-size image

     

Therapeutic approaches for the treatment of head and neck squamous cell carcinoma–An update on clinical trials

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common non-skin cancer with a tobacco consumption and infection with high-risk human papillomavirus (HPV) being major risk factors. Despite advances in numerous therapy modalities, survival rates for HNSCC have not improved considerably; a vast number of clinical outcomes have demonstrated that a combination strategy (the most well-known docetaxel, cisplatin, and 5-fluorouracil) is the most effective treatment choice. Immunotherapy that targets immunological checkpoints is being tested in a number of clinical trials, either alone or in conjunction with chemotherapeutic or targeted therapeutic drugs. Various monoclonal antibodies, such as cetuximab and bevacizumab, which target the EGFR and VEGFR, respectively, as well as other signaling pathway inhibitors, such as temsirolimus and rapamycin, are also being studied for the treatment of HNSCC. We have reviewed the primary targets in active clinical studies in this study, with a particular focus on the medications and drug targets used.     

26-Hydroxycholesterol and cholest-4-en-3-one,the first metabolites of cholesterol in potato plants

Etiolated potato sprouts convert administered cholesterol-4-¹⁴C to radioactive 26-hydroxycholesterol and cholest-4-en-3-one. These two steroids must be the first products of cholesterol metabolism in potato plants.     

Evidence that the Piromyces gene family encoding endo-l,4-mannanases arose through gene duplication

Abstract The sequences of two Piromyces cDNAs ( manB and manC ) encoding functional mannanases, defined as mannanase B (MANB) and mannanase C (MANC), revealed that both the cDNAs, and the encoded enzymes, exhibited extensive sequence identity with each other and with a previously described Piromyces mannanase. MANB and MANC, which belong to glycosyl hydrolase family 26, hydrolyse several forms of mannan but do not attack the other major plant structural polysaccharides. The data presented in this paper indicate that the Piromyces gene family encoding mannanases arose through gene duplication.     

Adrenomyeloneuropathy: increased accumulation of very long chain fatty acid in cultured skeletal muscle

Skeletal muscle cultures from a patient with the rare disease adrenomyeloneuropathy (AMN), challenged by the addition of an extra amount of docosanoic or hexacosanoic acid to the usual growth medium, accumulated much more of these fatty acids into several lipid classes than did control patient cultures. Triglycerides were particularly affected. These experiments are the first demonstrating an enhanced capacity of AMN cultured tissue to accumulate medium-derived fatty acids into cellular lipid. Cultured human skeletal muscle represents a new model system for evaluating the metabolic defect which results in the pathological accumulation of very-long-chain fatty-acids in AMN patients.     

Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner

1. Download : Download high-res image (234KB)
2. Download : Download full-size image